https://www.trialsitenews.com/what-is-the-zelenko-protocol-and-is-it-relevant-to-helping-prevent-covid-19-hospitalization/
What is the Zelenko Protocol and is it Relevant to Helping Prevent COVID-19 Hospitalization?
OCT 30, 2020 | COVID-19, HYDROXYCHLOROQUINE, NEWS
What is the Zelenko Protocol and is it Relevant to Helping Prevent COVID-19 Hospitalization
A growing divide is observed between most of the regulatory and research establishment that now shuns Hydroxychloroquine, the once embraced investigational therapy for COVID-19 now evidenced by a majority of studies to not be effective. However, critics, and there are many physicians in the field, argue that most of these studies were designed in a flawed manner. Now an outspoken physician, Dr. Vladimir Zelenko and a German team declare in a press release that they completed a retrospective study analyzing his patient data and that the findings have been accepted for publication after a rigorous peer review process. The paper can be found in the International Journal of Antimicrobial Agents.
What is the Key Hypothesis Here?
Dr. Zelenko’s main hypothesis based on the data showing that early intervention and treatment of high-risk patients with COVID-19 results in significantly few hospitalizations and deaths. This treatment regimen involving zinc, low-dose hydroxychloroquine, and azithromycin is also apparently known as, “The Zelenko Protocol.”
Why is this Retrospective Study Unique?
According to the independent physician-sponsor, only high-risk out-patients were treated with the triple-drug regimen. According to Dr. Zelenko, high risk patients represent those individuals that have a 5% to 10% chance of dying from COVID-19. This category includes patients over 60, as well as those under 60 that have other medical issues or experience breathing problems. In this protocol all high-risk outpatients were treated at their initial visit, most within the first five days of the onset of symptoms. All patients were laboratory confirmed with COVID-19 infection.
Who Performed this Retrospective Analysis?
According to the sponsor, the retrospective analysis study was the result of the three doctors forming a rare synergy of industry, academia, and clinical medicine. The collaborators included Dr. Roland Derwand, a German physician and life science industry expert. The team also included Professor Martin Scholz, an independent consultant and adjunct professor for experimental medicine at Heinrich Heine University in Dusseldorf, Germany. It was these two German physician/researchers that first brought attention to “The Zelenko Protocol” in their published hypothesis paper about the importance of combining zinc with hydroxychloroquine as a method for treating COVID-19.
Who is Dr. Zelenko?
A family practitioner and major proponent of the use of hydroxychloroquine, zinc, and azithromycin to treat COVID-19, Dr. Zelenko has claimed to treat anywhere from 300 to 1,450 COVID-19 patients. According to the Physicians Weekly “Skeptical Scalpel Awards,” the publication was leery of the independent doctor’s claims declaring of his own research, “Those are mighty impressive numbers, but no one else has seen the data.” The author of this critique noted that a fact check at the website Snopes couldn’t verify his claims.